Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital, Montpellier
With
Ministry of Health, France
The aim of this study is to appreciate the tolerance of "on line" HDF treatment versus conventional high flux hemodialysis in term of adverse events occuring during dialysis sessions between day 30 and day 120 of treatment and to evaluate:
* Quality of life evaluated with the KDQOL questionnaire
* Incidence of cardiovascular events
* Influence of the technic on cardiovascular, inflammatory and infectious risk factors
* Mortality
Age
65–90
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient who has signed the written consent form
Patient aged \> 65 and \< 90 years
With creatinine clearance \< 10 mL/min
On dialysis for a minimum of 3 months, with 3 times a week hemodialysis sessions
Erythropoietin dosage needed to maintain hemoglobin at a constant level (range of hemoglobin: 9-13 g/dL without any variation of more than 2g/dL for less than 3 months)
Without any problem of vascular access
You may not be if
Patient aged \< 65 and \> 90 years
Presence of severe malnutrition (albumin \< 20 g/L)
Unstable clinical condition
Unipuncture or failed vascular access flow
Known problems of coagulation
Clareo Health | Tolerance of "on Line" Hemodiafiltration in Chronic Renal Failure Patients
